Jun 22, 2020
New Research Shows Pathnostics® Guidance® UTI Test More Accurate Predictor of Antibiotic Susceptibility
Jun 04, 2020
FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
May 26, 2020
New Publication Reveals Real-World Usage of Vibativ® In Patients With Bacteremia Or Endocarditis
May 11, 2020
Vibativ® Sustained Potency Confirmed In Two Surveillance Studies
Mar 24, 2020
Avails Medical, a pioneer in automated, accelerated antibiotic susceptibility testing for septic patients announced today the participation of OMRON VENTURES Co., Ltd. in its current equity financing round
Mar 23, 2020
Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
Mar 04, 2020
Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2019 Financial Results
Dec 02, 2019
Accelerate Diagnostics Appoints Louise Francesconi to its Board of Directors
Nov 25, 2019
New Study Reveals Real-World Usage of Vibativ® In a Variety Of Infections
Nov 05, 2019
Cumberland Pharmaceuticals To Announce Third Quarter 2019 Financial Results
Oct 23, 2019
Biomica to Collaborate With Weizmann Institute of Science to Develop a Selective Treatment Against Antibiotic Resistant Bacteria
Oct 15, 2019
New Study Reveals Superiority Of Vibativ® Over Vancomycin In Select Patients With Bacterial Pneumonia
Oct 08, 2019
Vast Therapeutics Receives Qualified Infectious Disease Product Status for BIOC11
Oct 03, 2019
Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes
Sep 26, 2019
Acute Bacterial Skin and Skin Structure Infections Pipeline Insight Report 2019
Sep 18, 2019
Accelerate Diagnostics Highlights Clinical Endpoints Achieved Across Mayo Clinic/UCLA, University of Iowa, and UAMS Studies
Sep 10, 2019
Selux Diagnostics Selected to Lead IDWeek 2019 Panel Presentation, Poster Session
Sep 06, 2019
Specific Diagnostics Receives Investment from Telegraph Hill Partners to Commercialize Critical Drug Susceptibility Technology for Clinical Microbiology Labs
Aug 02, 2019
Accelerate Diagnostics Expands Antimicrobials in New CE-Marked Accelerate PhenoTest(TM) BC kit
Jul 08, 2019
Accelerate Diagnostics Schedules Call to Review Second Quarter 2019 Results